文献速递乳房整形与再造显微修复重建

加速康复外科是显微乳房再造的新标准吗?

Is Enhanced Recovery the New Standard of Care in Microsurgical Breast Reconstruction?
PubMed 文献 · Plast Reconstr Surg · 2017-01-01

该研究在单一癌症中心比较了加速康复路径实施前后行DIEP或游离TRAM皮瓣乳房再造患者的结局。结果显示加速康复路径组住院时间从5.0天缩短至4.0天,术后阿片类药物消耗从70.5mg降至46.0mg,30天并发症发生率无差异。

要点

  • 加速康复路径可缩短显微乳房再造住院时间1天。
  • 加速康复路径降低术后阿片类药物消耗。
  • 30天并发症发生率未见差异。

核心结论

  • 多术者采用加速康复路径行DIEP或TRAM皮瓣再造可显著降低阿片类药物消耗并缩短住院1天。

研究设计与样本

  • 单中心历史对照研究,纳入连续91例患者(加速康复组42例,对照组49例)。

主要发现

  • 加速康复组平均住院时间4.0天,对照组5.0天(p<0.0001)。
  • 加速康复组术后总吗啡当量消耗46.0mg,对照组70.5mg(p=0.003)。
  • 两组30天并发症发生率无差异(p=0.6)。

关键数值与推荐

  • 加速康复核心措施包括用酮咯酸和脂质体布比卡因腹横肌平面阻滞替代静脉患者自控镇痛,以及术中目标导向液体管理。

临床怎么用

  • 对行DIEP或游离TRAM皮瓣乳房再造的患者可考虑实施加速康复路径以减少阿片类用量并缩短住院。

局限性

  • 单中心历史对照设计,证据等级为治疗性III级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: At present, there are limited data available regarding the use and feasibility of enhanced recovery pathways for patients undergoing microsurgical breast reconstruction. The authors sought to assess patient outcomes before and after the introduction of an enhanced recovery pathway that was adopted at a single cancer center. METHODS: A multidisciplinary enhanced recovery pathway was developed for patients undergoing deep inferior epigastric perforator or free transverse rectus abdominis myocutaneous flap breast reconstruction. Core elements of the enhanced recovery pathway included substituting intravenous patient-controlled analgesia with ketorolac and transversus abdominis plane blocks using liposomal bupivacaine, as well as intraoperative goal-directed fluid management. Patients who underwent surgery between April and August of 2015 using the enhanced recovery pathway were compared with a historical control cohort. The primary endpoints were hospital length of stay and total postoperative opioid consumption. RESULTS: In total, 91 consecutive patients were analyzed (enhanced recovery pathway, n = 42; pre-enhanced recovery pathway, n = 49). Mean hospital length of stay was significantly shorter in the enhanced recovery pathway group than in the pre-enhanced recovery pathway group (4.0 days versus 5.0 days; p < 0.0001). Total postoperative morphine equivalent consumption was also lower in the enhanced recovery pathway group (46.0 mg versus 70.5 mg; p = 0.003). There was no difference in the incidence of 30-day complications between the groups (p = 0.6). CONCLUSION: The adoption of an enhanced recovery pathway for deep inferior epigastric perforator and transverse rectus abdominis myocutaneous flap reconstruction by multiple surgeons significantly decreased opioid consumption and reduced length of stay by 1 day. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Afonso A, Oskar S, Tan KS, et al. Is Enhanced Recovery the New Standard of Care in Microsurgical Breast Reconstruction? Plast Reconstr Surg. 2017. PMID: 28092334. doi:10.1097/PRS.0000000000003235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。